PT-141 serves as a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors across the body, causing to enhanced sexual response. Research studies have suggested that PT-141 may remarkably manage a variety of sexual dysfunctions in both m